≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Anuria and oliguria

Endpoint Browser

R18_ANURIA_OLIGU

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — R34
  • Cause of death: ICD-10 — R34

2 out of 7 registries used, show all original rules.

238

4. Check minimum number of events

None

238

5. Include endpoints

None

238

6. Filter based on genotype QC (FinnGen only)

238

Control definitions (FinnGen only)

Control exclude
R18_SYMPTOMS_SIGNS_INVOLVI_URINARY_SYSTEM

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
R3
Name in latin
Anuria

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 238 92 146
Unadjusted period prevalence (%) 0.05 0.03 0.06
Median age at first event (years) 66.88 63.12 69.26

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
212
Matched controls
2121
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R34
ICD-10 Finland
Anuria and oliguria
+∞
304.7
212
*
R33
ICD-10 Finland
Retention of urine
138.3
58.4
60
6
UKC02
NOMESCO Finland
Cystoscopy
9.6
33.7
76
116
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
7.0
25.4
70
139
R31
ICD-10 Finland
Unspecified haematuria
21.8
24.0
35
19
N17.9
ICD-10 Finland
Acute renal failure, unspecified
12.1
22.1
41
41
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
10.9
18.5
36
39
J01MA02
ATC
ciprofloxacin; systemic
3.7
18.0
115
513
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
5.3
17.4
58
140
C03CA01
ATC
furosemide; systemic
3.1
13.7
110
544
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
4.6
13.3
49
129
TK800
NOMESCO Finland
Hemodialysis
13.6
12.4
21
17
J01EA01
ATC
trimethoprim; systemic
3.4
12.4
72
278
TKC20
NOMESCO Finland
Catheterisation of bladder
6.0
12.4
35
68
TKC22
NOMESCO Finland
Catheterisation instruction
24.6
11.8
16
7
N18.8
ICD-10 Finland
Other chronic renal failure
11.0
11.3
21
21
R39.1
ICD-10 Finland
Other difficulties with micturition
22.9
10.8
15
7
R35
ICD-10 Finland
Polyuria
9.9
10.3
20
22
U07
ICPC
Urine symptom/complaint other
6.2
9.4
25
45
ZXD05
NOMESCO Finland
Urgent procedure
2.6
9.4
88
453
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.6
9.3
44
143
K59.0
ICD-10 Finland
Constipation
6.3
9.2
24
42
XKD00
NOMESCO Finland
Uroflowmetry
3.2
9.2
53
198
N30.0
ICD-10 Finland
Acute cystitis
3.8
9.2
40
122
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.2
9.1
53
200
E86
ICD-10 Finland
Volume depletion
10.7
8.7
16
16
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
3.1
8.7
51
194
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
17.2
8.7
13
8
U08
ICPC
Urinary retention
21.1
8.6
12
6
A06AD11
ATC
lactulose; oral
3.0
8.3
52
205
A41.9
ICD-10 Finland
Sepsis, unspecified
6.4
8.2
21
36
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.5
8.1
28
69
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
8.3
8.0
17
22
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.4
7.9
82
437
U05
ICPC
Urination problems other
6.8
7.9
19
30
A11CC03
ATC
alfacalcidol; systemic
8.6
7.7
16
20
R07.4
ICD-10 Finland
Chest pain, unspecified
2.5
7.5
68
333
KED22
NOMESCO Finland
Transurethral resection of prostate
4.7
7.5
25
59
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.9
7.4
30
86
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
7.8
7.3
16
22
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.3
7.3
38
133
N05AH04
ATC
quetiapine; oral
3.1
7.1
40
148
T36
ICD-10 Finland
Poisoning by systemic antibiotics
8.0
7.0
15
20
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.9
7.0
44
176
N19
ICD-10 Finland
Unspecified kidney failure
5.1
6.9
21
45
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
23.4
6.7
9
*
N17.8
ICD-10 Finland
Other acute renal failure
12.8
6.7
11
9
J01DA01
ATC
[U] cefalexin; systemic
2.2
6.6
135
952
N18.0
ICD-10 Finland
End-stage renal disease
10.5
6.6
12
12
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.8
6.6
27
78
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
6.6
101
633
N06AX11
ATC
mirtazapine; oral
2.3
6.6
69
364
J01CA08
ATC
pivmecillinam; oral
2.3
6.5
74
405
G04CA02
ATC
tamsulosin; oral
2.3
6.5
70
374
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
71.9
6.5
7
*
Z94.0
ICD-10 Finland
Kidney transplant status
14.9
6.5
10
7
TPX10
NOMESCO Finland
Implantation of vascular injection port
8.6
6.4
13
16
N03AX16
ATC
pregabalin; oral
2.5
6.4
56
269
N03AG01
ATC
valproic acid; systemic, rectal
5.1
6.4
19
40
ZX120
NOMESCO Finland
Intravenous
3.5
6.3
29
93
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.5
6.3
29
93
XKD06
NOMESCO Finland
Physiologic investigation of micturition
7.1
6.1
14
21
H02AB04
ATC
methylprednisolone; systemic
2.9
6.1
38
150

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002032) Base excess in Venous blood by calculation
60
168
4.44
20.05
15.7
3.4
mmol/l
0.8
1.7
0.92
47
127
(3021447) Carbon dioxide [Partial pressure] in Venous blood
60
169
4.41
19.89
15.7
3.4
kpa
5.8
5.7
0.22
55
162
(3000991) Gas panel - Venous blood
53
136
4.73
19.76
16.0
7.5
—
—
—
0
0
(3012544) pH of Venous blood
60
182
4.07
17.87
15.9
3.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
109
507
3.12
16.40
7.2
3.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
110
521
3.07
15.94
9.1
4.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
65
236
3.41
14.61
20.3
5.8
mmol/l
1.1
1.0
1.08
59
216
(3024354) Oxygen [Partial pressure] in Venous blood
49
148
3.91
14.50
12.1
3.0
kpa
4.4
4.4
0.13
44
141
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
122
648
2.81
13.81
7.6
3.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
71
288
3.09
13.14
6.3
4.4
mmol/l
0.8
0.8
1.17
66
274
(3030467) Casts [#/volume] in Urine by Automated count
100
497
2.75
12.63
7.3
3.0
e6/l
0.5
0.4
0.33
85
365
(36304419) Bacteria [Presence] in Urine
96
478
2.69
11.96
7.5
3.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
40
121
3.77
11.70
2.8
1.6
—
—
—
0
0
(3026782) Osmolality of Urine
80
370
2.75
11.45
6.0
2.7
mosm/kgh2o
517.6
557.3
0.73
74
304
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
55
210
3.11
11.14
2.7
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
55
210
3.11
11.14
2.8
1.8
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
16
25
6.79
9.94
1.9
1.6
u/ml
103.4
100.7
—
5
6
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
15
22
7.21
9.85
2.2
1.5
u/ml
198.1
222.0
—
9
10
(3002582) Erythrocytes [#/volume] in Urine
101
555
2.42
9.84
8.4
3.1
e6/l
417.1
188.3
0.24
87
422
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
67
304
2.68
9.78
3.1
1.8
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
17
29
6.24
9.73
2.1
1.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
126
767
2.37
9.68
12.0
4.8
g/l
33.1
35.1
3.49
118
713
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
51
202
2.94
9.60
4.2
3.5
umol/l
10.8
8.2
0.31
43
175
(3018095) Leukocytes [#/volume] in Urine
110
634
2.37
9.55
9.3
3.4
e6/l
162.3
109.9
0.38
92
448
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
137
869
2.36
9.51
20.5
7.0
mmol/l
1.2
1.2
0.78
119
730
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
24
58
4.49
9.42
3.8
9.6
u/ml
0.3
0.3
0.18
17
35
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
143
933
2.33
9.18
11.0
6.2
umol/l
12.9
13.2
0.08
137
879
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
15
24
6.60
9.10
2.2
1.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
62
282
2.62
8.93
5.5
2.8
e6/l
2.2
2.3
0.03
40
154
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
96
539
2.31
8.68
4.1
2.4
u/l
48.7
55.9
1.86
90
497
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
127
801
2.26
8.67
19.9
6.4
mmol/l
1.2
1.2
0.95
118
728
(3032080) INR in Blood by Coagulation assay
122
759
2.25
8.59
15.6
9.7
inr
1.4
1.3
0.13
29
232
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
63
296
2.53
8.45
5.2
2.7
e6/l
1.6
1.1
0.47
42
166
(3018418) pH of Serum or Plasma
93
521
2.29
8.40
11.3
3.7
ph
7.4
7.4
0.99
17
109
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
13
20
6.82
8.15
1.2
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
17
35
5.15
8.01
1.5
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
17
35
5.15
8.01
1.5
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
16
33
5.13
7.52
6.4
2.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
21
56
4.02
7.25
1.3
1.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
149
1048
2.13
7.21
9.8
4.9
mmol/l
7.1
6.7
1.04
142
970
(3052851) Hemolysis interference index of Serum or Plasma
18
43
4.45
7.15
4.5
2.9
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
54
254
2.46
7.13
5.6
2.3
%
20.0
22.5
1.01
49
222
(3049717) Cytology report of Urine Cyto stain
19
49
4.13
6.85
2.3
3.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
116
762
2.02
6.56
7.7
4.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
47
216
2.47
6.49
9.6
8.1
mmol/l
1.0
1.2
0.12
40
169
(3037467) Urinalysis macro (dipstick) panel - Urine
159
1189
2.02
6.00
9.6
4.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
17
45
3.99
5.92
2.1
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
70
400
2.06
5.68
4.4
2.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
17
47
3.82
5.59
9.8
3.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
92
583
1.94
5.55
8.2
5.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
65
371
2.03
5.24
2.4
2.1
mg/l
1.1
1.4
0.74
48
288
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
35
155
2.47
5.20
6.0
4.8
ng/l
318.9
237.1
0.27
30
141
(3023520) Reticulocytes [#/volume] in Blood
37
170
2.39
5.08
2.5
2.7
e9/l
74.8
66.0
0.75
29
139
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
83
522
1.91
5.04
5.7
3.4
u/l
37.1
35.1
0.11
74
493
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
19
61
3.30
5.04
5.3
3.0
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
62
354
2.02
4.97
4.5
2.9
mmol/l
2.5
2.5
0.00
46
319
(3013115) Eosinophils [#/volume] in Blood
122
884
1.78
4.57
9.5
5.4
e9/l
0.2
0.2
0.05
103
782
(40758558) Short blood count panel - Blood
69
422
1.89
4.49
13.0
6.3
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
111
786
1.77
4.47
9.4
5.3
%
0.5
0.6
1.12
103
734
(3019069) Monocytes/100 leukocytes in Blood
113
809
1.76
4.35
9.7
5.6
%
8.2
8.8
1.12
104
759
(3006504) Eosinophils/100 leukocytes in Blood
113
809
1.76
4.35
9.4
5.3
%
2.7
2.9
0.24
104
750
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
31
4.02
4.31
2.2
1.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
20
73
2.90
4.30
15.9
15.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
105
740
1.75
4.24
6.2
4.0
ng/l
99.0
50.4
0.33
83
546
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
22
86
2.72
4.19
1.6
1.9
g/l
1.7
1.4
0.30
16
76
(3019309) Folate [Moles/volume] in Red Blood Cells
61
366
1.90
4.18
2.0
1.8
nmol/l
1403.8
1139.6
1.13
49
271
(3002030) Lymphocytes/100 leukocytes in Blood
114
825
1.73
4.18
9.6
5.4
%
23.6
26.9
1.77
104
769
(3001604) Monocytes [#/volume] in Blood
117
854
1.73
4.15
8.3
5.1
e9/l
0.7
0.6
0.94
96
736
(3006315) Basophils [#/volume] in Blood
117
860
1.71
4.00
8.2
5.1
e9/l
0.0
0.0
0.03
96
751
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
14
43
3.40
3.97
3.4
1.9
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
112
815
1.71
3.96
9.9
5.2
%
61.2
57.9
1.39
102
765
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
10
24
4.31
3.92
2.3
1.8
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
100
707
1.71
3.92
5.2
2.7
ug/l
185.7
141.9
0.88
94
648
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
11
7.48
3.89
1.1
1.1
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
118
875
1.69
3.87
8.5
5.2
e9/l
1.7
1.9
0.66
101
777
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
9
15
6.19
3.85
1.0
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
14
44
3.32
3.84
3.4
2.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
33
164
2.18
3.77
2.8
1.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
33
164
2.18
3.77
2.8
2.0
%
1.5
1.6
0.19
26
138
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
33
167
2.13
3.61
3.0
2.5
u/l
29.1
29.1
0.00
33
134
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
14
46
3.17
3.59
1.4
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
13
6.32
3.53
1.0
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
8
13
6.32
3.53
1.3
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
11
31
3.67
3.52
9.1
2.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
14
47
3.10
3.47
1.4
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
24
108
2.36
3.45
1.9
1.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
79
540
1.69
3.42
4.9
2.5
—
—
—
0
0
(3020891) Body temperature
19
77
2.59
3.39
9.3
3.8
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
14
48
3.04
3.36
1.4
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
24
110
2.31
3.32
2.1
1.3
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
15
54
2.90
3.32
1.2
3.9
ratio
1.9
1.2
—
5
6
(3006576) Bicarbonate [Moles/volume] in Blood
6
7
8.75
3.28
11.3
7.9
mmol/l
25.8
26.4
—
6
7
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
11
33
3.45
3.23
4.2
3.5
%
64.2
57.3
0.48
11
33
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
10
28
3.68
3.23
2.4
1.7
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
87
618
1.64
3.23
8.2
3.1
mmol/l
2.3
2.3
1.06
77
551
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
15
5.48
3.22
2.5
2.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
57
362
1.76
3.19
6.4
3.5
ng/l
50.1
155.2
1.69
51
290
(3042936) Bacteria identified in Isolate by Culture
46
276
1.83
3.11
3.4
2.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
162
1346
1.64
3.10
14.7
7.2
u/l
89.2
81.5
1.11
154
1248
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
11
34
3.34
3.10
2.9
1.9
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
6
8
7.66
3.07
1.5
1.6
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
6
8
7.66
3.07
51.3
25.5
nmol/l
1599.3
1189.3
—
6
8
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
6
8
7.66
3.07
20.5
15.5
nmol/l
943.0
826.1
—
6
8
(46235355) HIV 1 and 2 tests - Meaningful Use set
42
246
1.86
3.06
2.7
1.9
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
9
21
4.41
3.02
1.9
1.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
71
486
1.66
3.01
2.5
2.0
mg/l
3.3
3.2
0.19
64
419
(3019060) Gas panel - Arterial blood
27
136
2.11
2.99
12.2
7.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
36
202
1.92
2.98
2.6
1.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
102
765
1.58
2.98
19.8
9.9
e9/l
0.0
0.0
0.59
70
631
(3003181) Sodium [Moles/volume] in Urine
11
35
3.25
2.97
1.3
1.5
mmol/l
63.3
55.9
—
6
29
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
30
3.44
2.94
3.6
1.8
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
9
22
4.21
2.91
1.7
2.2
pg
31.9
32.8
—
9
22
(40760888) Immunoglobulin light chains.free panel - Serum
11
36
3.16
2.84
1.2
5.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
18
4.56
2.82
1.1
1.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
126
1006
1.54
2.71
18.4
8.7
e9/l
5.2
4.3
1.57
108
881
(3011648) Oxygen content in Venous blood
6
10
6.12
2.71
2.8
1.0
%
9.8
9.0
—
6
10
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
19
4.32
2.70
1.0
1.5
nmol/l
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
95
717
1.54
2.63
2.4
2.0
pmol/l
93.1
94.0
0.07
54
393
(44790048)
7
15
4.77
2.61
3.4
2.0
—
—
—
0
0
(44790049)
7
15
4.77
2.61
3.4
2.0
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
7
15
4.77
2.61
1.0
1.2
—
—
—
0
0
(44790047)
7
15
4.77
2.61
3.4
2.0
—
—
—
0
0
(44806118)
7
15
4.77
2.61
3.4
2.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
7
15
4.77
2.61
1.0
1.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
8
20
4.10
2.59
1.1
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
35
206
1.82
2.51
1.7
1.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
13
51
2.64
2.49
3.3
1.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
65
455
1.59
2.48
4.7
2.8
umol/l
407.0
5345.0
1.45
57
379
(3021960) Folate [Moles/volume] in Serum or Plasma
65
457
1.58
2.43
2.0
1.6
nmol/l
18.4
21.1
0.81
60
378
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
12
5.10
2.41
1.2
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
9
28
3.30
2.33
3.4
2.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
11
41
2.76
2.31
2.8
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
57
394
1.59
2.28
1.6
1.9
pmol/l
515.9
447.5
0.57
48
339
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
29
3.18
2.25
1.0
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
127
1043
1.47
2.23
5.8
3.1
u/l
74.1
53.3
1.14
122
972
(1001926) Buprenorphine [Presence] in Urine by Screen method
10
36
2.86
2.23
3.0
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
73
537
1.52
2.21
6.1
4.0
mg/mmol
28.9
8.9
1.51
57
356
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
8
24
3.41
2.20
1.3
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
6
14
4.37
2.16
4.8
2.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
72
532
1.51
2.13
5.6
3.1
mmol/l
6.3
7.8
2.45
66
434
(3042631) Mycobacterium sp identified in Specimen
8
25
3.27
2.11
2.8
3.6
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
9
31
2.98
2.09
3.8
3.0
e9/l
6.4
4.6
—
9
31
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
10
5.08
2.08
2.6
2.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
5
10
5.08
2.08
1.2
1.0
—
—
—
0
0
(3036489) Thrombin time
14
63
2.30
2.05
3.6
4.0
s
20.5
22.6
1.26
14
56
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
15
4.07
2.05
1.3
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
24
134
1.88
2.04
5.1
3.5
%
0.1
1.0
—
8
47
(3027944) Amphetamines [Presence] in Urine
11
44
2.57
2.04
2.8
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
11
44
2.57
2.04
2.9
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
11
44
2.57
2.04
2.8
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
33
205
1.71
1.99
2.9
1.6
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
7
21
3.40
1.98
2.0
1.3
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
14
65
2.23
1.92
1.1
1.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
68
507
1.48
1.91
5.2
3.2
mg/l
142.6
146.3
0.01
54
346
(4035726)
25
145
1.81
1.90
1.2
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
16
79
2.10
1.90
1.5
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
22
3.25
1.89
3.3
1.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
38
551
0.63
1.84
3.8
3.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
79
616
1.42
1.74
3.7
3.4
ng/l
2896.1
1831.5
0.75
71
528
(3023419) Bacteria identified in Sputum by Culture
7
24
2.97
1.73
2.7
2.9
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
21
119
1.84
1.72
5.5
3.6
%
0.0
0.3
—
8
37
(3023410) Appearance of Cerebral spinal fluid
5
13
3.90
1.72
1.0
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
22
127
1.81
1.71
5.2
3.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
50
362
1.48
1.61
7.4
3.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
7
26
2.74
1.59
1.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
10
44
2.33
1.55
3.0
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
15
3.38
1.53
1.4
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
15
3.38
1.53
6.4
2.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
15
3.38
1.53
2.8
1.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
27
2.64
1.52
2.1
1.8
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
6
21
2.90
1.51
3.7
4.1
nmol/l
44.6
3.4
—
6
21
(3011288) Drugs identified in Urine by Screen method
7
28
2.54
1.46
4.1
1.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
7
28
2.54
1.46
1.1
1.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
21
126
1.73
1.45
5.5
3.5
%
0.0
0.2
—
8
42
(21494890) Protein electrophoresis panel - 24 hour Urine
5
16
3.17
1.44
1.0
3.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
10
46
2.23
1.42
1.4
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
11
53
2.13
1.41
1.3
1.8
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
100
837
1.34
1.37
10.2
4.7
estimate
0.0
0.0
0.00
21
169
(3013707) Erythrocyte sedimentation rate by Westergren method
144
1272
1.33
1.36
4.8
3.9
mm/h
17.3
12.5
2.42
135
1164
(3004588) Protein electrophoresis panel - Serum or Plasma
21
129
1.69
1.35
1.4
2.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
101
851
1.32
1.31
7.8
3.6
estimate
0.0
0.0
0.00
21
168
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
69
1.94
1.31
1.3
2.2
g/l
3.7
3.6
—
8
46
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
69
1.94
1.31
1.3
2.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
69
1.94
1.31
1.3
2.2
g/l
7.1
7.1
—
8
49
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
24
2.54
1.31
2.5
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
18
2.81
1.29
2.0
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
19
117
1.68
1.22
5.2
3.5
%
0.1
0.5
—
7
34
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
19
2.67
1.22
1.4
1.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
99
839
1.31
1.22
7.8
3.5
estimate
0.0
0.0
0.00
20
175
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
26
2.34
1.19
1.3
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
6
26
2.34
1.19
1.0
1.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
40
2.03
1.13
1.9
1.3
—
—
—
0
0
(4010399)
19
120
1.63
1.12
1.4
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
7
31
2.30
1.11
1.6
2.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
21
2.41
1.09
1.4
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
49
380
1.36
1.09
7.3
4.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
19
121
1.62
1.09
1.1
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
32
2.22
1.09
2.6
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
7
32
2.22
1.09
3.0
1.6
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
7
33
2.15
1.06
1.0
1.5
pmol/l
92.3
81.5
—
7
33
(3000093) Morphology [Interpretation] in Blood Narrative
5
22
2.30
1.04
1.2
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
30
0.00
0.98
0.0
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
32
0.00
0.96
0.0
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
15
94
1.64
0.93
1.5
1.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
6
29
2.10
0.90
2.8
7.9
mmol/l
6.2
6.4
—
6
23
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
22
153
1.48
0.89
14.0
4.0
mmol/l
1.2
1.2
1.15
22
135
(3021901) Oxygen saturation in Capillary blood
8
42
1.94
0.89
10.5
3.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
8
42
1.94
0.89
1.7
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
56
457
1.29
0.89
1.5
1.4
—
—
—
0
0
(4034850)
10
56
1.82
0.89
17.5
11.8
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
21
146
1.48
0.86
18.9
6.9
mmol/l
2.4
1.7
0.23
14
115
(3007164) IgA [Mass/volume] in Serum or Plasma
41
325
1.32
0.81
1.3
1.4
g/l
2.7
2.7
0.07
25
179
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
25
0.00
0.79
0.0
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
27
0.00
0.78
0.0
1.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
27
0.00
0.78
0.0
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
27
0.00
0.78
0.0
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
27
0.00
0.78
0.0
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
131
1194
1.22
0.76
5.2
4.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
29
221
1.36
0.74
1.3
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
160
1491
1.22
0.73
5.1
4.5
mu/l
2.0
2.0
0.01
142
1339
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
7
39
1.82
0.73
1.1
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
25
2.02
0.73
1.2
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
9
57
1.60
0.72
4.7
1.9
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
181
1716
1.23
0.66
44.1
15.2
mg/l
34.1
24.9
2.35
166
1377
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
11
165
0.65
0.65
1.4
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
58
497
1.22
0.62
6.7
3.2
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
5
30
1.68
0.62
3.4
1.7
%
89.5
90.1
—
5
30
(3019150) Specific gravity of Urine by Refractometry
46
385
1.24
0.61
7.6
3.8
kg/l
1.0
1.0
—
8
62
(3005033) Fetal Nuchal fold Thickness US
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
19
141
1.38
0.58
1.6
2.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
6
35
1.73
0.58
1.5
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
76
673
1.19
0.58
8.0
3.7
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
11
73
1.53
0.57
33.0
9.2
kpa
9.3
8.1
2.54
11
68
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
155
1637
0.85
0.56
5.9
5.1
mmol/l
2.4
2.6
1.37
147
1478
(3022145) Colonoscopy Study observation
22
169
1.33
0.55
1.4
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
73
649
1.18
0.53
3.0
2.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
17
127
1.36
0.51
3.4
3.0
ml/min/173m2
33.4
60.7
—
5
61
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
9
65
1.40
0.51
2.0
1.9
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
150
1583
0.86
0.51
5.1
4.5
mmol/l
1.3
1.4
2.25
141
1440
(3009343) pH of Capillary blood
20
154
1.33
0.50
19.8
6.7
ph
7.4
7.4
—
5
16
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
104
955
1.16
0.50
3.8
2.8
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
7
45
1.57
0.49
1.3
1.1
nmol/l
3.0
0.8
—
7
40
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
27
218
1.27
0.49
5.8
3.8
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
46
1.54
0.48
4.3
2.0
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
7
46
1.54
0.48
9.3
2.1
g/l
116.9
124.1
—
7
36
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
7
49
1.44
0.46
1.4
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
8
56
1.44
0.43
1.8
1.9
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
32
1.57
0.42
1.2
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
10
70
1.45
0.42
3.9
4.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
128
1204
1.14
0.42
4.1
3.7
pmol/l
15.3
14.8
1.15
111
1070
(40761536) Microorganisms panel - Urine sediment
20
159
1.28
0.41
13.4
3.4
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
15
0.00
0.41
0.0
1.0
—
36.3
—
0
7
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.0
—
562.8
—
0
8
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.0
—
273.0
—
0
8
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.2
—
0.1
—
0
8
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
40
346
1.19
0.40
1.3
1.2
u/ml
0.8
1.2
—
7
82
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
35
1.44
0.39
1.6
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
38
437
0.84
0.39
3.8
3.0
ug/l
0.7
0.8
0.14
33
285
(3019550) Sodium [Moles/volume] in Serum or Plasma
182
1756
1.15
0.39
53.8
18.1
mmol/l
138.7
139.6
3.28
175
1706
(3013512) EKG study
63
568
1.15
0.38
5.0
3.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
54
482
1.16
0.38
8.9
3.8
estimate
0.0
0.0
0.00
20
163
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
37
1.36
0.37
3.0
2.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
148
1544
0.89
0.35
8.3
6.3
mmol/mol
42.7
40.7
1.17
140
1429
(3023103) Potassium [Moles/volume] in Serum or Plasma
182
1761
1.14
0.35
54.2
18.1
mmol/l
4.0
4.0
0.19
174
1712
(3000492) Spirometry study
18
145
1.26
0.35
1.4
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
153
1593
0.89
0.35
5.1
4.6
mmol/l
4.2
4.4
1.58
143
1458
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
57
622
0.89
0.29
4.2
4.5
%
21.2
21.7
0.08
32
306
(3019225) pH of Specimen
19
159
1.21
0.27
6.5
4.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
180
1751
1.11
0.27
39.5
14.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
10
127
0.78
0.26
1.9
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
14
114
1.24
0.25
2.6
1.7
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
6
84
0.71
0.24
1.3
1.3
—
62.2
—
0
8
(3010813) Leukocytes [#/volume] in Blood
182
1863
0.90
0.24
60.4
22.4
e9/l
7.8
6.9
4.38
175
1806
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
28
247
1.15
0.24
1.3
1.2
u/ml
1.0
15.7
—
10
95
(3026361) Erythrocytes [#/volume] in Blood
182
1862
0.90
0.23
60.4
22.3
e12/l
4.2
4.5
6.76
176
1804
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
12
97
1.25
0.23
2.6
2.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
15
125
1.21
0.23
1.7
2.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
5
39
1.29
0.23
1.0
1.3
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7
95
0.73
0.22
2.3
2.5
—
15.8
—
0
5
(3007461) Platelets [#/volume] in Blood
182
1860
0.91
0.22
60.7
22.4
e9/l
242.8
241.4
0.10
176
1809
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(44806420)
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
10
0.00
0.21
0.0
2.8
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
10
0.00
0.21
0.0
2.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.7
—
4.5
—
0
8
(3014599) Egg white IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.5
—
4.1
—
0
7
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
149
1533
0.92
0.20
4.5
4.1
mmol/l
1.4
1.3
1.19
136
1383
(3000330) Specific gravity of Urine by Test strip
12
100
1.21
0.18
6.1
4.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
10
121
0.82
0.18
33.4
7.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
18
157
1.16
0.18
1.6
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
8
68
1.18
0.17
2.3
1.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
80
767
1.06
0.14
4.8
5.0
ug/l
4.8
2.6
0.72
71
668
(3009542) Hematocrit [Volume Fraction] of Blood
152
1487
1.06
0.14
47.3
16.5
%
36.3
39.3
2.58
103
1000
(3022621) pH of Urine by Test strip
14
123
1.15
0.13
5.9
2.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
152
1549
0.95
0.12
38.6
14.5
ml/min/173m2
70.8
76.9
1.66
127
1269
(3002256) Pathology report gross observation
22
203
1.09
0.10
1.5
1.4
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
5
61
0.82
0.08
1.4
2.1
u/l
31.2
41.4
—
5
54
(1002224) Polysomnography panel
7
68
1.03
0.08
1.0
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
8
75
1.07
0.07
2.3
1.9
—
—
—
0
0
(40768443) Skin Pathology biopsy report
9
87
1.04
0.07
1.2
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
9
101
0.89
0.06
2.1
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
163
1612
1.04
0.06
5.3
4.7
mmol/l
6.4
6.0
0.98
148
1450
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
176
1777
0.96
0.06
20.0
10.4
u/l
24.6
25.5
0.44
170
1707
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
20
211
0.94
0.04
8.5
8.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
26
252
1.04
0.02
1.5
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
21
205
1.03
0.00
4.1
4.6
%
30.5
31.8
0.25
16
137
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
130.3
—
0
8
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
8
0.00
0.00
0.0
1.1
—
3.8
—
0
8
(3035933) Granulocytes/100 leukocytes in Blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
10.8
—
0
5
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
6.0
—
240.1
—
0
7
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.8
—
991.2
—
0
9
(3015183) Erythrocyte sedimentation rate
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
7
70
1.00
0.00
10.3
2.9
mmol/l
4.3
4.0
—
7
62
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
9
95
0.95
0.00
1.2
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6
67
0.89
0.00
1.0
1.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
9
0.00
0.00
0.0
2.4
—
4.6
—
0
9
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
15.8
—
0
5

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: R18_ANURIA_OLIGU – Anuria and oliguria

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).